The research lab of Eleonora Tamilia at Boston Children's Hospital is a dynamic and innovative space dedicated to advancing neurological research and improving clinical practices.

With a focus on epilepsy, the lab is pioneering methods to optimize EEG (scalp or intracranial) and MEG data analysis and interpretation in children with drug-resistant epilepsy. In parallel, the team is actively identifying novel EEG biomarkers for identifying drug-resistant epilepsy by leveraging EEG signal processing and predictive AI.

Dr. Tamilia is also the director of the EMU Signal and Data Science Program, a cutting-edge initiative established in 2023, designed to integrate science into the clinical workflow within BCH Epilepsy Monitoring Unit (EMU).

Expanding its reach, the lab is also developing a new noninvasive method to assess feeding behavior in newborns through electromyography (EMG), aiming to enhance understanding of early developmental challenges.

Through a blend of advanced signal processing, neuroimaging, artificial intelligence, and interdisciplinary collaboration, the lab strives to translate complex data into meaningful clinical applications, ultimately improving outcomes and quality of life for children with neurological disorders or infants with early motor deficits.

Dr. Tamilia's current funded projects are:

• "Identifying Novel Network-based EEG Biomarkers of Drug-Resistant and Surgery-Resistant Epilepsy in Children",  2023 Pilot Research Grant by the Rosamund Stone Zander Translational Neuroscience Center (RSZ TNC) - PI: Tamilia.
• "Combining Brain Connectivity and Excitability to Plan Epilepsy Surgery in Children: A New Approach to Get the Most from Intracranial Electroencephalography", Role PI, NIH (NINDS) R03NS127044-01 - PI: Tamilia.
• "Developing A Novel Bedside Approach to Enable Objective Quantitative Feeding Assessment In the Newborn” - 2024 Institutional Centers for Clinical and Translational Research (ICCTR) Pediatric Clinical Research Pilot grant - PI: Tamilia.